Efficacy Study of Pristinamycin Versus Amoxicillin to Treat Tonsillitis Induced by Streptococcus in Children
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to demonstrate the non-inferiority, at the assessment
visit (V3 (D10/D14)), in terms of bacteriological efficacy of pristinamycin (PRI)
administered for 4 days versus amoxicillin (AMX) administered for 6 days in the treatment of
tonsillitis caused by GAS, in subjects aged between 6 and 25 in the per protocol (PP) group.